DMAA
Drugs Made In America Acquisition
$10.70
$0.00 (0%)Jul 27, 2026
Key metrics
The numbers that frame DMAA today
- Market cap
- $259.76M
- P/E (TTM)
- 39.0
- EV / FCF
- -685.3
- ROIC
- 2.8%
- Div yield
- 0%
- 52wk Low
- $10.22
- 52wk High
- $10.72
Growth
Revenue and earnings trend for DMAA
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about DMAA
Is Drugs Made In America Acquisition a good buy?
Hold. Drugs Made In America Acquisition has weak quality and mixed momentum. The setup is mixed. We think Drugs Made In America Acquisition is selling at a fair price.
What is the market capitalization of DMAA?
Drugs Made In America Acquisition's market capitalization is $259.76M.
What is the P/E ratio for DMAA stock?
Drugs Made In America Acquisition's current P/E ratio is 39.
What is the 52-week high for DMAA stock?
The 52-week high for Drugs Made In America Acquisition is $10.72. The current close of $10.70 is 0.2% below that high.
What is the 52-week low for DMAA stock?
The 52-week low for Drugs Made In America Acquisition is $10.22. The current close of $10.70 is 4.7% above that low.
Does DMAA stock pay dividends?
Drugs Made In America Acquisition does not currently show a dividend per share in the company data.